Moderna, Inc.

ISIN US60770K1079

 | 

WKN A2N9D9

Market cap (in EUR)
15.497 m
Country
Verenigde Staten
Sector
Gezondheidszorg
Dividend yield
0,00%
 

Overview

Quote

Description

Moderna, Inc. houdt zich bezig met de ontwikkeling van transformatieve geneesmiddelen op basis van boodschapperribonucleïnezuur. De productpijplijn van het bedrijf omvat de volgende modaliteiten: profylactische vaccins, kankervaccins, intratumorale immuno-oncologie, lokale regeneratieve therapeutica, systemisch uitgescheiden therapeutica, geïnhaleerde longtherapeutica en systemische intracellulaire therapeutica. Het is actief in de volgende geografische segmenten: Verenigde Staten, Europa en Rest van de Wereld. Het bedrijf werd in 2010 opgericht door Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi en Kenneth R. Chien en het hoofdkantoor is gevestigd in Cambridge, MA.
Show more Show less
Gezondheidszorg Biofarmaceutica Niet-Systeemspecifieke Biofarmaceutica Verenigde Staten

Chart

Financials

Key metrics

Market capitalisation, EUR 15.497 m
EPS, EUR -6,43
P/B ratio 2,1
P/E ratio 27,9
Dividend yield 0,00%

Income statement (2025)

Revenue, EUR 1.723 m
Net income, EUR -2.501 m
Profit margin -145,16%

What ETF is Moderna, Inc. in?

There are 19 ETFs which contain Moderna, Inc.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Moderna, Inc. is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
Vanguard LifeStrategy 80% Equity UCITS ETF (EUR) Accumulating 0.06%
Equity
World
Multi-Asset Strategy
1,008
Vanguard LifeStrategy 20% Equity UCITS ETF Distributing 0.02%
Equity
World
Multi-Asset Strategy
15
UBS S&P 500 Scored & Screened UCITS ETF USD dis 0.05%
Equity
United States
Social/Environmental
511
Vanguard LifeStrategy 80% Equity UCITS ETF Distributing 0.06%
Equity
World
Multi-Asset Strategy
76
Vanguard LifeStrategy 60% Equity UCITS ETF Accumulating 0.04%
Equity
World
Multi-Asset Strategy
774
Vanguard LifeStrategy 40% Equity UCITS ETF Accumulating 0.02%
Equity
World
Multi-Asset Strategy
216
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.02%
Equity
World
Social/Environmental
508
Leverage Shares -5x Short Nasdaq 100 ETP 0.63%
Equity
United States
Technology
5
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.28%
Equity
United States
Small Cap
202
Vanguard S&P 500 UCITS ETF (USD) Distributing 0.03%
Equity
United States
42,425
Goldman Sachs Alpha Enhanced US Equity Active UCITS ETF USD (Acc) 0.15%
Equity
United States
258
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 1.61%
Equity
United States
Health Care
Biotech
46
Leverage Shares 5x Long Nasdaq 100 ETP 0.63%
Equity
United States
Technology
28
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.04%
Equity
North America
Social/Environmental
25
Vanguard S&P 500 UCITS ETF (USD) Accumulating 0.03%
Equity
United States
27,453
iShares Core S&P 500 UCITS ETF USD (Dist) 0.03%
Equity
United States
17,769
Vanguard LifeStrategy 60% Equity UCITS ETF Distributing 0.04%
Equity
World
Multi-Asset Strategy
96
Vanguard LifeStrategy 40% Equity UCITS ETF Distributing 0.02%
Equity
World
Multi-Asset Strategy
38
Vanguard LifeStrategy 20% Equity UCITS ETF Accumulating 0.02%
Equity
World
Multi-Asset Strategy
95

Performance

Returns overview

YTD +47.34%
1 month -9.22%
3 months +0.05%
6 months +83.35%
1 year +60.34%
3 years -67.58%
5 years -73.06%
Since inception (MAX) +142.19%
2025 -31.22%
2024 -57.11%
2023 -45.95%
2022 -23.33%

Monthly returns in a heat map

Risk

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF returns include dividend payments (if applicable).
Show more Show less

Risk overview

Volatility 1 year 62.87%
Volatility 3 years 60.35%
Volatility 5 years 64.40%
Return per risk 1 year 0.96
Return per risk 3 years -0.52
Return per risk 5 years -0.36
Maximum drawdown 1 year -31.68%
Maximum drawdown 3 years -86.93%
Maximum drawdown 5 years -95.12%
Maximum drawdown since inception -95.12%

Rolling 1 year volatility

— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.